In Advanced Hodgkin Lymphoma, New 6-Drug Regimen Exceeds Standard for Efficacy, Tolerability

A phase 3 randomized trial has shown that compared with BEACOPP, a standard seven-drug regimen for classic advanced ...

JUNE 26, 2024